Legionnaires’ disease kills roughly one in ten people who develop it, though that figure masks enormous variation depending on who gets infected and how quickly they receive the right antibiotics. For otherwise healthy adults treated promptly, the odds of survival are good. For people who are elderly, immunosuppressed, or who acquire the infection in a hospital, the fatality rate climbs steeply. Understanding who sits at the high end of that risk spectrum, and what drives those differences, matters far more than any single headline number.
The People Most Likely to Die From It
Surveillance data have consistently identified the same cluster of risk factors that predict a fatal outcome. Being elderly or male, having kidney disease or cancer, being immunosuppressed, and acquiring the infection inside a hospital all independently raise the likelihood of death.1PubMed. Surveillance for Legionnaires’ disease. Risk factors for morbidity and mortality. That list is not surprising if you think about what the body needs to fight a severe lung infection: intact immune function, strong respiratory reserve, and kidneys capable of handling the stress of high fever and aggressive antibiotic therapy. When any of those systems are already compromised, Legionella gets the upper hand.
Age stands out because it bundles several vulnerabilities together. Older adults are more likely to have chronic lung disease, weakened immune responses, and the kinds of comorbidities that complicate pneumonia treatment. They are also more likely to present with unusual symptoms, which can delay the correct diagnosis. A case report of an elderly man who showed up with confusion and gastrointestinal complaints rather than any cough or shortness of breath illustrates the problem: doctors who are not thinking about Legionella may not test for it until the infection has progressed.2PubMed Central. Community-Acquired Legionnaires’ Disease Presenting With Gastrointestinal and Neurological Symptoms Without Respiratory Complaints in an Elderly Male
Immunosuppression and Transplant Recipients
People with weakened immune systems face a qualitatively different disease. Impaired immunity delays the clearance of the bacteria, giving the infection time to spread and cause complications that a healthy immune system would have prevented.3PubMed Central. Multidisciplinary Management of Legionella Disease in Immunocompromised Patients This applies to people on immunosuppressive medications after organ transplants, those receiving chemotherapy, and those with HIV or other conditions that impair immune function.
Transplant recipients deserve special attention because the data on them are striking. In one 15-year review at a tertiary medical center, transplant recipients made up the majority of Legionnaires’ disease diagnoses, and the mortality attributed to the infection ran between roughly a quarter and a third of cases depending on the Legionella species involved.4PubMed. Legionnaires’ disease in transplant recipients: A 15-year retrospective study in a tertiary referral center A separate series of solid organ transplant recipients found a lower but still concerning mortality rate of about 14%, with the authors noting that the introduction of rapid urinary antigen testing had accelerated diagnosis and allowed faster treatment.5PubMed. Clinical features and outcomes of Legionnaires’ disease in solid organ transplant recipients The gap between these figures likely reflects differences in how sick the patients were, how quickly they were diagnosed, and which Legionella species were involved. But both numbers are well above the overall average, and they underscore that immunosuppression is the single strongest predictor of a bad outcome.
How People Get Infected
Legionella bacteria live in freshwater environments and thrive in warm water. They become dangerous when water containing the bacteria is turned into a fine mist that people breathe in. This can happen through cooling towers, showerheads, faucets, hot tubs, decorative fountains, and any other device that aerosolizes water.6PubMed Central. Ten Questions Concerning the Aerosolization and Transmission of Legionella in the Built Environment You cannot catch it from another person. It is purely an environmental exposure.
While cooling towers have been the focus of many high-profile outbreaks, potable water distribution systems are actually the primary reservoir for the bacteria. Aspiration of contaminated water, where a tiny amount of water goes down the wrong pipe into the lungs, is another transmission route, and one that is particularly relevant in hospital settings where patients may have impaired swallowing reflexes.7Journal AWWA. Environmental Aspects of Legionnaires’ Disease This is why hospital-acquired cases carry a higher death rate: the patients are already sick, their immune defenses are already taxed, and the mode of transmission may be harder to prevent.
Pontiac Fever, the Milder Cousin
Not every Legionella infection causes the severe pneumonia known as Legionnaires’ disease. The same family of bacteria also causes Pontiac fever, a self-limiting flu-like illness that involves fever, muscle aches, and headache but no pneumonia. Pontiac fever resolves on its own within a few days and is not considered life-threatening. What determines whether someone develops the lethal pneumonia or the mild fever is still an open question. Strains of the same Legionella species and serogroup have been associated with both outcomes, and researchers have not fully identified which bacterial or host factors tip the balance one way or the other.8PubMed. Comparative analysis of virulence traits between a Legionella feeleii strain implicated in Pontiac fever and a strain that caused Legionnaires’ disease For the purposes of fatality risk, Pontiac fever is largely irrelevant, but it is worth knowing that not every encounter with Legionella means a life-threatening illness.
Why Delayed Diagnosis Kills
Legionnaires’ disease is a form of pneumonia, and its symptoms overlap heavily with other types of community-acquired pneumonia: fever, cough, shortness of breath, muscle pain. The standard first-line antibiotics for pneumonia, such as beta-lactams, do not work against Legionella because the bacteria live inside human cells where those drugs cannot reach them effectively. This means a patient started on the wrong antibiotic will not improve, and the delay in appropriate treatment has been directly linked to worse outcomes.9PubMed Central. Legionnaires’ Disease: Update on Diagnosis and Treatment
The most widely used diagnostic tool is the urinary antigen test, which can give results within hours. But it has a meaningful blind spot: it reliably detects only one serogroup of one species, Legionella pneumophila serogroup 1.10PubMed. Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy That serogroup causes the majority of cases, but not all of them. Infections caused by other species or serogroups can be missed entirely if physicians rely solely on the urine test. Culture of respiratory specimens and PCR-based tests can fill the gap, but they take longer or are not available everywhere. The practical result is that some Legionnaires’ disease cases are never correctly identified, which inflates the true case fatality rate among undiagnosed patients who never receive the right antibiotics.
Treatment Options and What the Evidence Shows
Two classes of antibiotics are effective against Legionella: macrolides (such as azithromycin) and fluoroquinolones (such as levofloxacin). Current guidelines recommend either one. A systematic review and meta-analysis comparing the two found no meaningful difference in mortality, with death rates of about 7% in both groups and no significant differences in time to fever resolution, length of hospital stay, or complications.11PubMed Central. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis A head-to-head comparison of levofloxacin versus azithromycin in a large cohort similarly found no significant differences in any clinical outcome.12PubMed. Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis
That said, there is an ongoing debate about whether quinolones might be preferable in severe cases or in immunocompromised patients. Individual case reports describe patients who deteriorated on azithromycin and rapidly improved after switching to levofloxacin, and some clinicians argue that quinolones penetrate lung tissue more effectively at high doses.13PubMed Central. Severe Legionnaires’ disease refractory to azithromycin: Are quinolones superior to macrolides? But controlled trials strong enough to settle the question do not yet exist. For most patients, the key variable is not which drug class is chosen but how quickly treatment begins.
Occupational Groups With Elevated Risk
Certain jobs put people in regular contact with aerosolized water or poorly maintained water systems. An analysis of cases across 39 U.S. jurisdictions found that workers in transportation, construction, and healthcare support had the highest rates. Truck drivers made up the majority of the transportation group, and construction laborers roughly half of the construction group. Healthcare support workers had the single highest incidence rate ratio of any occupation studied.14PubMed Central. Legionnaires’ disease in transportation, construction and other occupations in 39 US jurisdictions, 2014–2016
A broader review of occupational legionellosis spanning decades of published cases found that industrial settings accounted for the majority of workplace-associated cases, followed by office buildings and healthcare facilities. Fatalities in occupational settings were exclusively associated with the pneumonic form of the disease, though the overall occupational mortality rate was about 4%, suggesting that working-age adults who are otherwise healthy have a lower risk of death than the general Legionnaires’ disease population.15PubMed. Legionellosis in the occupational setting Less common exposure settings have included decontamination work at environmental disaster sites, where living and working conditions created ideal conditions for Legionella growth.16PubMed Central. Legionnaires’ disease as an occupational risk related to decontamination work after the Fukushima nuclear disaster: A case report
Long-Term Health After Surviving the Infection
Surviving Legionnaires’ disease does not always mean returning to baseline health. A study tracking nearly 300 patients with confirmed Legionnaires’ disease found that more than half were hospitalized at least once within the next five years. Patients who had been admitted to an ICU during their initial infection were roughly twice as likely to have subsequent hospitalizations compared to those who had not needed intensive care. Among the most common new diagnoses in the years following infection were acute kidney failure, acute respiratory failure, and unspecified pneumonia, suggesting that the initial damage to the lungs and kidneys can leave lasting vulnerabilities.17PubMed Central. Health after Legionnaires’ disease: A description of hospitalizations up to 5 years after Legionella pneumonia
This is an underappreciated aspect of the disease’s toll. Public health discussions tend to focus on the acute fatality rate, but the burden on survivors, particularly those who had severe cases, extends well beyond the initial hospitalization. Anyone recovering from a serious bout should be aware that respiratory and renal problems may surface in subsequent years and should keep their physicians informed of their history.
Weather, Humidity, and Seasonal Patterns
Legionnaires’ disease cases spike in warm, humid weather, and the relationship is not subtle. A U.S. study found that when temperatures were between 60°F and 80°F and relative humidity exceeded 80%, the odds of a community-acquired pneumonia case being caused by Legionella were about three times higher than under drier conditions.18PubMed Central. Weather-Dependent Risk for Legionnaires’ Disease, United States This makes intuitive sense: warm temperatures promote bacterial growth in water systems, and high humidity helps aerosolized droplets stay suspended in the air longer.
Regional variation adds complexity. A study from Catalonia found that atmospheric temperature correlated with Legionnaires’ disease incidence, but average relative humidity actually showed an inverse correlation, which runs counter to the U.S. findings.19PubMed. Impact of meteorological factors on Legionella colonisation of water systems and the incidence of Legionnaires’ disease Climate geography likely explains the discrepancy: the interplay between outdoor humidity, indoor water-system conditions, and how people use buildings varies from region to region. What both studies agree on is that temperature is a driver, and that Legionnaires’ disease is not uniformly distributed across the calendar year.
Preventing Legionella Growth in Buildings
Because Legionella colonizes building water systems, prevention is fundamentally an engineering and maintenance problem. The bacteria multiply in warm stagnant water, particularly in the temperature range between roughly 77°F and 113°F. Keeping hot water systems above 131°F (55°C) at all points in the distribution network is considered the best approach, though achieving that uniformly is difficult in large or aging buildings.20Water Science and Technology. Resistance of Legionella to disinfection in hot water distribution systems
Where consistent temperature control is not feasible, chemical disinfection fills the gap. An Italian hospital maintained zero Legionnaires’ disease cases over a decade using a combination of a water safety plan, monochloramine disinfection, and extensive environmental sampling. The fraction of water samples testing positive for Legionella never exceeded 1% in any year.21PubMed Central. Water Safety Plan, Monochloramine Disinfection and Extensive Environmental Sampling Effectively Control Legionella and Other Waterborne Pathogens in Nosocomial Settings: The Ten-Year Experience of an Italian Hospital Newer approaches using mineral oxychloride as a continuous disinfectant have shown similar promise, reducing microbial activity in hospital water systems to near-zero levels over a six-month treatment period.22Archives of Infectious Diseases & Therapy. Mineral Oxychloride: A Continuous Disinfection Method for Legionella Control in Healthcare Water Systems The common thread is that no single intervention is enough. Effective Legionella control requires ongoing monitoring, not a one-time fix.
Co-Infections and Compounding Risk
Legionnaires’ disease rarely exists in a clinical vacuum. Patients who develop it often have other active infections or chronic conditions that complicate the picture. During the COVID-19 pandemic, cases of co-infection with both Legionella and SARS-CoV-2 were documented, and the combination was associated with increased mortality. The risk factors for severe outcomes with either infection overlap heavily: older age and immunosuppression.23PubMed Central. Co-infection with Legionella and SARS-CoV-2: a case report This is not unique to COVID; bacterial co-infection during any viral respiratory illness tends to worsen outcomes. For Legionnaires’ disease, the practical implication is that people who are already fighting one infection and then encounter contaminated water aerosols face a doubly dangerous situation.
Genetic Variation in Susceptibility
Most discussions of Legionnaires’ disease risk focus on environmental exposure and immune status, but there is evidence that your genetic makeup influences whether you develop the disease at all. A study examining variants in the gene for Toll-like receptor 4, a protein involved in the early immune response to bacteria, found that certain genetic variants were associated with resistance to Legionnaires’ disease. People carrying a specific variant were significantly less likely to develop the infection when exposed.24PubMed Central. Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease
The finding was counterintuitive because the same genetic variants had been linked to increased susceptibility to other infections. The researchers concluded that an innate immune receptor can produce either a helpful or harmful inflammatory response depending on which pathogen it encounters. This area of research is still in its early stages, and no one is genetically screening patients to assess their Legionella risk. But it helps explain a real-world puzzle: why, during outbreaks, only a fraction of exposed people develop the disease while most walk away unaffected. The answer involves not just lung health and immune status but individual genetic wiring that varies from person to person.
The 1976 Outbreak That Named the Disease
The name “Legionnaires’ disease” comes from a 1976 outbreak at an American Legion convention in Philadelphia, where a mysterious respiratory illness killed 34 attendees. The investigation that followed led to the identification of an entirely new family of pathogenic bacteria, the Legionellaceae.25PubMed Central. Legionnaires disease: historical perspective Before that outbreak, Legionella infections almost certainly occurred but were lumped in with undiagnosed pneumonias. Retrospective analyses later identified earlier cases stretching back decades. The Philadelphia event was not the beginning of the disease but the beginning of our ability to recognize it, and the surveillance infrastructure built in its aftermath remains the foundation of how cases are tracked and outbreaks identified today.